Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 338

1.

IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer.

Sgarbanti M, Remoli AL, Marsili G, Ridolfi B, Borsetti A, Perrotti E, Orsatti R, Ilari R, Sernicola L, Stellacci E, Ensoli B, Battistini A.

J Virol. 2008 Apr;82(7):3632-41. doi: 10.1128/JVI.00599-07. Epub 2008 Jan 23.

2.

Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.

Jacqué JM, Fernández B, Arenzana-Seisdedos F, Thomas D, Baleux F, Virelizier JL, Bachelerie F.

J Virol. 1996 May;70(5):2930-8.

3.

Analysis of the signal transduction pathway leading to human immunodeficiency virus-1-induced interferon regulatory factor-1 upregulation.

Sgarbanti M, Marsili G, Remoli AL, Ridolfi B, Stellacci E, Borsetti A, Ensoli B, Battistini A.

Ann N Y Acad Sci. 2004 Dec;1030:187-95.

PMID:
15659797
4.
5.

The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.

Gómez-Gonzalo M, Carretero M, Rullas J, Lara-Pezzi E, Aramburu J, Berkhout B, Alcamí J, López-Cabrera M.

J Biol Chem. 2001 Sep 21;276(38):35435-43. Epub 2001 Jul 16.

6.
7.
8.
9.

T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.

Lemieux AM, Paré ME, Audet B, Legault E, Lefort S, Boucher N, Landry S, van Opijnen T, Berkhout B, Naghavi MH, Tremblay MJ, Barbeau B.

J Biol Chem. 2004 Dec 17;279(51):52949-60. Epub 2004 Oct 1.

10.

Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.

McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.

Virology. 2000 Sep 1;274(2):262-77.

11.

Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.

Roof P, Ricci M, Genin P, Montano MA, Essex M, Wainberg MA, Gatignol A, Hiscott J.

Virology. 2002 Apr 25;296(1):77-83.

14.
15.

Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription.

Kundu M, Guermah M, Roeder RG, Amini S, Khalili K.

J Biol Chem. 1997 Nov 21;272(47):29468-74.

16.

NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.

Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, Greene WC.

EMBO J. 2006 Jan 11;25(1):139-49. Epub 2005 Dec 1.

17.

Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.

Williams SA, Kwon H, Chen LF, Greene WC.

J Virol. 2007 Jun;81(11):6043-56. Epub 2007 Mar 21.

18.

Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.

Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B.

J Virol. 2000 Apr;74(8):3740-51.

19.

Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors.

Sgarbanti M, Borsetti A, Moscufo N, Bellocchi MC, Ridolfi B, Nappi F, Marsili G, Marziali G, Coccia EM, Ensoli B, Battistini A.

J Exp Med. 2002 May 20;195(10):1359-70.

20.

Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.

Hazan U, Thomas D, Alcami J, Bachelerie F, Israel N, Yssel H, Virelizier JL, Arenzana-Seisdedos F.

Proc Natl Acad Sci U S A. 1990 Oct;87(20):7861-5.

Items per page

Supplemental Content

Write to the Help Desk